{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:28:54Z","timestamp":1786681734704,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05806-8","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:04:18Z","timestamp":1786680258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergic anticancer effects of morin hydrate and sorafenib delivered via polymeric iron oxide nanoparticles for the treatment of triple-negative breast cancer"],"prefix":"10.1007","author":[{"given":"Mingjun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"5806_CR1","doi-asserted-by":"publisher","first-page":"138982","DOI":"10.1016\/j.molstruc.2024.138982","volume":"1315","author":"HM Alharbi","year":"2024","unstructured":"Alharbi HM, Eldin ZE, Taha M, Elbeltagi S (2024) Preparation, characterization, and anticancer evaluation of polydatin conjugated with zinc MOF and encapsulated by liponiosomes as a potential nanotool-induce apoptosis. J Mol Struct 1315:138982. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138982","journal-title":"J Mol Struct"},{"key":"5806_CR2","doi-asserted-by":"publisher","first-page":"e70752","DOI":"10.1111\/jcmm.70752","volume":"29","author":"HM Alharbi","year":"2025","unstructured":"Alharbi HM, Alqahtani T, Alqalawi NA, Alsayegh SA, Almaghrabi BA, Sarkar S, Uti DE, Dhara B (2025) Exploring the potential of Zein nanoparticles in personalised cancer therapy, highlighting their various methodologies, applications and challenges. J Cell Mol Med 29:e70752","journal-title":"J Cell Mol Med"},{"key":"5806_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12668-023-01261-4","volume":"14","author":"RKM Al-Ziyadi","year":"2024","unstructured":"Al-Ziyadi RKM, Hayati N, Rezaei MR, Es-haghi A (2024) Preparation and characterization of chitosan-coated nanostructured lipid carriers (CS-NLC) containing (6)-gingerol and investigating their toxicity against MCF-7 breast cancer cell line. Bionanoscience 14:153\u2013163. https:\/\/doi.org\/10.1007\/s12668-023-01261-4","journal-title":"Bionanoscience"},{"key":"5806_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/pat.5931","volume":"34","author":"E Bahmani","year":"2023","unstructured":"Bahmani E, Dizaji BF, Talaei S, Koushkbaghi S, Yazdani H, Abadi PG, Akrami M, Shahrousvand M, Jazi FS, Irani M (2023) Fabrication of poly (\u03f5-caprolactone)\/paclitaxel (core)\/chitosan\/zein\/multi-walled carbon nanotubes\/doxorubicin (shell) nanofibers against MCF-7 breast cancer. Polym Adv Technol 34:789\u2013799","journal-title":"Polym Adv Technol"},{"key":"5806_CR5","doi-asserted-by":"publisher","first-page":"6164871","DOI":"10.1155\/ijbm\/6164871","volume":"2025","author":"EM Bian","year":"2025","unstructured":"Bian EM, Moghadam A (2025) Synthesis and characterization of Fe3O4\/Chitosan\/TiO2 nanoparticle novel nanocarrier and investigation of in vitro release of Vancomycin on HeLa cancer cell. Int J Biomater 2025:6164871","journal-title":"Int J Biomater"},{"key":"5806_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/ph17030320","volume":"17","author":"LAdeA Campos","year":"2024","unstructured":"Campos LAdeA, Neto AFS, Scavuzzi AML, Lopes ACDS, Santos-Magalh\u00e3es NS, Cavalcanti IMF (2024) Ceftazidime\/Tobramycin Co-Loaded chitosan-coated zein nanoparticles against antibiotic-resistant and biofilm-producing Pseudomonas aeruginosa and Klebsiella pneumoniae. Pharmaceuticals (Basel) 17:320","journal-title":"Pharmaceuticals (Basel)"},{"key":"5806_CR7","doi-asserted-by":"publisher","first-page":"100237","DOI":"10.1016\/j.onano.2025.100237","volume":"22","author":"T Chuacharoen","year":"2025","unstructured":"Chuacharoen T, Astete CE, Sabliov CM (2025) Resveratrol loaded zein nanoparticles for inhibiting proliferation of osteosarcoma cells: synthesis, characterization, release profile, and cytotoxicity. OpenNano 22:100237","journal-title":"OpenNano"},{"key":"5806_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00289-026-06309-5","volume":"83","author":"M Dhavalkumar","year":"2026","unstructured":"Dhavalkumar M, Dudhat K, Shah S, Pethani T, Ansari J, Vora T, Hingora J, Sherasiya K, Jiyani R, Borkhataria C (2026) Role of polymeric carriers in amorphous solid dispersions: comprehensive review of stabilization mechanisms, dissolution behavior, and FDA-approved formulations. Polym Bull 83:285","journal-title":"Polym Bull"},{"key":"5806_CR9","doi-asserted-by":"publisher","first-page":"21521","DOI":"10.1038\/s41598-020-76504-5","volume":"10","author":"M Ebadi","year":"2020","unstructured":"Ebadi M, Bullo S, Buskara K, Hussein MZ, Fakurazi S, Pastorin G (2020) Release of a liver anticancer drug, sorafenib from its PVA\/LDH- and PEG\/LDH-coated iron oxide nanoparticles for drug delivery applications. Sci Rep 10:21521. https:\/\/doi.org\/10.1038\/s41598-020-76504-5","journal-title":"Sci Rep"},{"key":"5806_CR10","doi-asserted-by":"publisher","first-page":"125492","DOI":"10.1016\/j.ijpharm.2025.125492","volume":"674","author":"S Elbeltagi","year":"2025","unstructured":"Elbeltagi S, Al-zharani M, Nasr FA, Ismail AM, El-Tohamy HM, Abdelbased KM, Eldin ZE (2025) Multifunctional sorafenib-loaded MXene for enhanced cancer therapy: in vitro and in vivo study based on chemotherapy\/photothermal therapy approach. Int J Pharm 674:125492. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125492","journal-title":"Int J Pharm"},{"key":"5806_CR11","doi-asserted-by":"publisher","first-page":"147294","DOI":"10.1016\/j.ijbiomac.2025.147294","volume":"327","author":"S Elbeltagi","year":"2025","unstructured":"Elbeltagi S, Al-zharani M, Nasr FA, Ismail AM, El-Tohamy HM, Abdelbased KM, shakor AbakrA, Eldin ZE (2025) Unveiling the photothermal mechanism and therapeutic potential of quercetin-loaded MXene-ZMOF@Chitosan in MCF-7 breast cancer. Int J Biol Macromol 327:147294. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147294","journal-title":"Int J Biol Macromol"},{"key":"5806_CR12","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2025.155978","author":"A El-Mallul","year":"2025","unstructured":"El-Mallul A, Tomasiuk R, Jaworski P, Mughali S (2025) Advancements and future directions of iron oxide nanoparticles in cancer therapy. Wspolczesna Onkol. https:\/\/doi.org\/10.5114\/wo.2025.155978","journal-title":"Wspolczesna Onkol"},{"key":"5806_CR13","doi-asserted-by":"publisher","first-page":"e6536","DOI":"10.1002\/aoc.6536","volume":"36","author":"K Giriraj","year":"2022","unstructured":"Giriraj K, Kasim MSM, Balasubramaniam K, Thangavel SK, Venkatesan J, Suresh S, Shanmugam P, Karri C (2022) Various coordination modes of new coumarin Schiff bases toward Cobalt (III) ion: synthesis, spectral characterization, in vitro cytotoxic activity, and investigation of apoptosis. Appl Organomet Chem 36:e6536. https:\/\/doi.org\/10.1002\/aoc.6536","journal-title":"Appl Organomet Chem"},{"key":"5806_CR14","doi-asserted-by":"publisher","first-page":"155932582614468","DOI":"10.1177\/15593258261446840","volume":"24","author":"X Guo","year":"2026","unstructured":"Guo X, Yang J, Zhu S, Hirad AH, Arulselvan P, Hu Z (2026) Naringenin-loaded zinc nitrate and manganese nitrate nanoparticles induce caspase-dependent apoptosis in kidney cancer A-498 cells. Dose-Response 24:15593258261446840","journal-title":"Dose-Response"},{"key":"5806_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/mc.23827","volume":"64","author":"Y Haga","year":"2025","unstructured":"Haga Y, Ray R, Ray RB (2025) Silmitasertib in combination with cabozantinib impairs liver cancer cell cycle progression, induces apoptosis, and delays tumor growth in a preclinical model. Mol Carcinog 64:72\u201382","journal-title":"Mol Carcinog"},{"key":"5806_CR16","doi-asserted-by":"crossref","unstructured":"Hamdi M, Al-Tabakha MM, Ali IH, Khalil IA (2026) Combinatorial anti-mitotic activity of loratadine\/5-fluorouracil loaded zein tannic acid nanoparticles in breast cancer therapy: In silico, in vitro and cell studies. Int J Nanomed 1\u201327","DOI":"10.2147\/IJN.S564050"},{"key":"5806_CR17","doi-asserted-by":"crossref","unstructured":"Jalali A, Razooqi NF, Nasser R, Salehzadeh A (2026) Apoptosis induction and enhanced CASP9 expression in liver cancer cells by crocin-conjugated magnetite iron oxide nanoparticles. Heliyon 122026","DOI":"10.1016\/j.heliyon.2026.e44528"},{"key":"5806_CR18","doi-asserted-by":"publisher","first-page":"114319","DOI":"10.1016\/j.colsurfb.2024.114319","volume":"245","author":"CS Jayalakshmi","year":"2025","unstructured":"Jayalakshmi CS, Haider M, Rawas-Qalaji M, Sanpui P (2025) Curcumin-loaded zein nanoparticles: a quality by design approach for enhanced drug delivery and cytotoxicity against cancer cells. Colloids Surf B Biointerfaces 245:114319","journal-title":"Colloids Surf B Biointerfaces"},{"key":"5806_CR19","doi-asserted-by":"publisher","first-page":"112107","DOI":"10.1016\/j.colsurfb.2021.112107","volume":"208","author":"Z Jin","year":"2021","unstructured":"Jin Z, Dun Y, Xie L, Jiang W, Sun X, Hu P, Zheng S, Yu Y (2021) Preparation of doxorubicin-loaded porous iron Oxide@ polydopamine nanocomposites for MR imaging and synergistic photothermal\u2013chemotherapy of cancer. Coll Surf B Biointerfaces 208:112107. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112107","journal-title":"Coll Surf B Biointerfaces"},{"key":"5806_CR20","doi-asserted-by":"publisher","first-page":"1634225","DOI":"10.3389\/fnano.2025.1634225","volume":"7","author":"A Karimova","year":"2025","unstructured":"Karimova A, Hajizada S, Shirinova H, Nuriyeva S, Gahramanli L, Mehdiyeva A, Eyvazova G, Sadikhov T, Lenz N, Nasirova I (2025) Dextran-coated Fe3O4 nanoparticles with ratio-dependent drug loading: structural characterization and cytotoxicity in colorectal cancer cells. Front Nanotechnol 7:1634225","journal-title":"Front Nanotechnol"},{"key":"5806_CR21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/cancers18081203","volume":"18","author":"A Karimova","year":"2026","unstructured":"Karimova A, Shirinova H, Sadikhov T, Hajibabazade J, Hajizada S, Tazhbayev Y, Atakhanov AA, Babayev SN, Reissfelder C, Yagublu V (2026) Light-activated iron oxide nanoparticles in cancer treatment: synergistic roles in photothermal and photodynamic therapy. Cancers (Basel) 18:1203","journal-title":"Cancers (Basel)"},{"key":"5806_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.actbio.2023.11.019","volume":"173","author":"X Li","year":"2024","unstructured":"Li X, Niu J, Deng L, Yu Y, Zhang L, Chen Q, Zhao J, Wang B, Gao H (2024) Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer. Acta Biomater 173:432\u2013441","journal-title":"Acta Biomater"},{"key":"5806_CR23","doi-asserted-by":"publisher","first-page":"104624","DOI":"10.1016\/j.critrevonc.2025.104624","volume":"207","author":"X Li","year":"2025","unstructured":"Li X, Zhang X, Yin S, Nie J (2025) Challenges and prospects in HER2-positive breast cancer-targeted therapy. Crit Rev Oncol Hematol 207:104624","journal-title":"Crit Rev Oncol Hematol"},{"key":"5806_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.apsb.2018.09.001","volume":"9","author":"R Liu","year":"2019","unstructured":"Liu R, Hu C, Yang Y, Zhang J, Gao H (2019) Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment. Acta Pharm Sin B 9:410\u2013420. https:\/\/doi.org\/10.1016\/j.apsb.2018.09.001","journal-title":"Acta Pharm Sin B"},{"key":"5806_CR25","doi-asserted-by":"publisher","first-page":"139750","DOI":"10.1016\/j.ijbiomac.2025.139750","volume":"293","author":"M Liu","year":"2025","unstructured":"Liu M, Huang T, Liu Y, Chen L, Liao S, Gong X, Bello MG, Zhu W, Huang S, Zhang X (2025) Loading curcumin on hyperbranched polymers functionalized Zein via the phenol-yne click reaction as pH-responsive drug delivery system for chemotherapy and photodynamic therapy. Int J Biol Macromol 293:139750","journal-title":"Int J Biol Macromol"},{"key":"5806_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2026.108040","author":"P-L Liu","year":"2026","unstructured":"Liu P-L, Wang J-L, Dong Y-Y, Liu H, Lei J-J, Xu B, Liao X-R, Han D, He Z-H, Cheng S-X (2026) Co-delivery of gefitinib and curcumin via zein-based nanoparticles to enhance EGFR signaling inhibition and prevent cancer progression. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2026.108040","journal-title":"J Drug Deliv Sci Technol"},{"key":"5806_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03992-w","author":"T Lu","year":"2026","unstructured":"Lu T, Zhu W, Lin C, Zhang Z, Lim LHK, Cui J (2026) Sorafenib nanomedicine in HCC: nano-bio interactions and combination therapies. J Nanobiotechnology. https:\/\/doi.org\/10.1186\/s12951-025-03992-w","journal-title":"J Nanobiotechnology"},{"key":"5806_CR28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ccell.2025.03.017","volume":"43","author":"D Ma","year":"2025","unstructured":"Ma D, Dai L-J, Wu X-R, Liu C-L, Zhao S, Zhang H, Chen L, Xiao Y, Li M, Zhao Y-Z (2025) Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer. Cancer Cell 43:1061\u20131075","journal-title":"Cancer Cell"},{"key":"5806_CR29","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/cbf.3863","volume":"41","author":"D Manica","year":"2023","unstructured":"Manica D, da Silva GB, da Silva AP, Marafon F, de O. Maciel SFV, Bagatini MD, Moreno M (2023) Curcumin promotes apoptosis of human melanoma cells by caspase 3. Cell Biochem Funct 41:1295\u20131304","journal-title":"Cell Biochem Funct"},{"key":"5806_CR30","first-page":"44","volume":"4","author":"SK Mousavi Majd","year":"2025","unstructured":"Mousavi Majd SK, Farahmand M, Safavi Sohi M, Jahanshiri S, Haji Mehdi Nouri Z (2025) A novel tool against an old scourge: A review of nanobiotechnology applications in breast cancer treatment. Micro Nano Bio Asp. 4:44\u201353","journal-title":"Micro Nano Bio Asp."},{"key":"5806_CR31","doi-asserted-by":"publisher","first-page":"e15087","DOI":"10.1016\/j.heliyon.2023.e15087","volume":"9","author":"Z Nie","year":"2023","unstructured":"Nie Z, Wang D, Wang S, Wang L (2023) Facile construction of irinotecan loaded mesoporous nano-formulation with surface-initiated polymerization to improve stimuli-responsive drug delivery for breast cancer therapy. Heliyon 9:e15087. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15087","journal-title":"Heliyon"},{"key":"5806_CR32","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2174\/0113892010299290240531101441","volume":"26","author":"M Nosrati-Oskouie","year":"2025","unstructured":"Nosrati-Oskouie M, Salavatizadeh M, Aghili-Moghaddam NS, Sathyapalan T, Kesharwani P, Tarighat-Esfanjani A, Sahebkar A (2025) Folate-modified curcumin-loaded nanoparticles for overcoming delivery challenges in cancer treatment: a narrative review. Curr Pharm Biotechnol 26:1423\u20131440","journal-title":"Curr Pharm Biotechnol"},{"key":"5806_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41523-025-00768-1","volume":"11","author":"S O\u2019Reilly","year":"2025","unstructured":"O\u2019Reilly S, Luis IV, Adam V, Razis ED, Urruticoechea A, Arahmani A, Carrasco E, Chua BH, Bliss J, Straehle C (2025) Advancing equitable access to innovation in breast cancer. NPJ Breast Cancer 11:71","journal-title":"NPJ Breast Cancer"},{"key":"5806_CR34","doi-asserted-by":"publisher","first-page":"21707","DOI":"10.1021\/acsanm.3c03923","volume":"6","author":"J Pe\u00f1a-Bahamonde","year":"2023","unstructured":"Pe\u00f1a-Bahamonde J, Herrera G, Lupini S, Arabaghian H, Rodrigues DF (2023) Zein nanoparticles for controlled intestinal drug release for the treatment of gastrointestinal infections. ACS Appl Nano Mater 6:21707\u201321720","journal-title":"ACS Appl Nano Mater"},{"key":"5806_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107307","author":"M Pourhossein","year":"2025","unstructured":"Pourhossein M, Pishbin F, Ataie A, Akrami M, Mostafavi E (2025) The theragnostic potential of polyaniline-decorated magnetic nanoparticles: a sorafenib carrier for chemo-photothermal therapy and imaging of hepatocellular carcinoma. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2025.107307","journal-title":"J Drug Deliv Sci Technol"},{"key":"5806_CR36","doi-asserted-by":"crossref","unstructured":"Rahim S, Mani A, Anirudhan TS (2026) An in-vivo and ex-vivo evaluation of folic acid targeted polyethylene glycol conjugated zein protein loaded curcumin for breast cancer therapy. Eur Polym J 114641","DOI":"10.1016\/j.eurpolymj.2026.114641"},{"key":"5806_CR37","doi-asserted-by":"publisher","first-page":"104120","DOI":"10.1016\/j.esmoop.2024.104120","volume":"10","author":"I Schlam","year":"2025","unstructured":"Schlam I, Loi S, Salgado R, Swain SM (2025) Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges. ESMO Open 10:104120","journal-title":"ESMO Open"},{"key":"5806_CR38","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1080\/15257770.2020.1740929","volume":"39","author":"N Shahabadi","year":"2020","unstructured":"Shahabadi N, Razlansari M (2020) In vitro spectroscopic investigation of groove binding interaction of Fe3O4@CaAl-LDH@L-Dopa with calf thymus DNA. Nucleosides Nucleotides Nucleic Acids 39:1020\u20131035. https:\/\/doi.org\/10.1080\/15257770.2020.1740929","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"5806_CR39","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/BF00557813","volume":"15","author":"V Sharma","year":"2023","unstructured":"Sharma V, Sharma JK, Kansay V, Sharma VD, Sheoran R, Singh M, Bera MK (2023) Chloramphenicol and gentamycin-encapsulated iron oxide nanoparticles as a nanocarrier for antibacterial efficacy via targeted drug delivery, Nano. Biomed Eng 15:170\u2013178","journal-title":"Biomed Eng"},{"key":"5806_CR40","doi-asserted-by":"publisher","first-page":"124701","DOI":"10.1016\/j.molliq.2024.124701","volume":"401","author":"SK Shukla","year":"2024","unstructured":"Shukla SK, Goyal M, Kanabar DD, Ayehunie S, Deore B, Sanhueza CA, Muth A, Gupta V (2024) Exploring the enhanced stability and therapeutic efficacy of sorafenib-cyclodextrin inclusion complex. J Mol Liq 401:124701. https:\/\/doi.org\/10.1016\/j.molliq.2024.124701","journal-title":"J Mol Liq"},{"key":"5806_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s10924-024-03451-x","author":"W Sun","year":"2024","unstructured":"Sun W, Li S (2024) Fabrication of co-delivery of bortezomib and vincristine loaded chitosan cross-linked polymeric nanoparticles: evaluation of anticancer activity and apoptosis induction in lung cancer cells. J Polym Environ. https:\/\/doi.org\/10.1007\/s10924-024-03451-x","journal-title":"J Polym Environ"},{"key":"5806_CR42","doi-asserted-by":"crossref","unstructured":"Tabassum R, Dilshad E (2024) A comparative anticancer analysis of iron oxide nanoparticles of Hippophae rhamnoides and Cichorium intybus found in the Karakoram Range of Gilgit Baltistan against liver cancer targeting the RhoA gene. Drug Dev Ind Pharm 1\u201310","DOI":"10.1080\/03639045.2024.2400209"},{"key":"5806_CR43","first-page":"353","volume":"10","author":"A Thenmozhi","year":"2025","unstructured":"Thenmozhi A, Abishek B, BavaDhareni P, Venkateshan N (2025) Advancing cervical cancer treatment: the promise of nanotechnology. Int J Pharm Res Appl 10:353\u2013357","journal-title":"Int J Pharm Res Appl"},{"key":"5806_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41523-025-00723-0","volume":"11","author":"P Turova","year":"2025","unstructured":"Turova P, Kushnarev V, Baranov O, Butusova A, Menshikova S, Yong ST, Nadiryan A, Antysheva Z, Khorkova S, Guryleva MV (2025) The Breast Cancer Classifier refines molecular breast cancer classification to delineate the HER2-low subtype. NPJ Breast Cancer 11:19","journal-title":"NPJ Breast Cancer"},{"key":"5806_CR45","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nprot.2006.55","volume":"1","author":"H van Genderen","year":"2006","unstructured":"van Genderen H, Kenis H, Lux P, Ungeth L, Maassen C, Deckers N, Narula J, Hofstra L, Reutelingsperger C (2006) In vitro measurement of cell death with the annexin A5 affinity assay. Nat Protoc 1:363\u2013367. https:\/\/doi.org\/10.1038\/nprot.2006.55","journal-title":"Nat Protoc"},{"key":"5806_CR46","doi-asserted-by":"publisher","first-page":"1177068","DOI":"10.3389\/fphar.2023.1177068","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yang Y, Zheng X, Shi J, Zhong L, Duan X, Zhu Y (2023) Application of iron oxide nanoparticles in the diagnosis and treatment of leukemia. Front Pharmacol 14:1177068","journal-title":"Front Pharmacol"},{"key":"5806_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng L-W, Ding Y, Chen Y-F, Cai Y-W, Wang L-P, Huang L, Liu C-C, Shao Z-M, Yu K-D (2025) Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther 10:49","journal-title":"Signal Transduct Target Ther"},{"key":"5806_CR48","doi-asserted-by":"crossref","unstructured":"Veeraraghavan J, De Angelis C, Gutierrez C, Liao FT, Sabotta C, Rimawi MF, Osborne CK, Schiff R (2025) HER2-Positive breast cancer treatment and resistance. A Guid Breast Cancer Res from Cell Heterog Mol Mech Ther 495\u2013525","DOI":"10.1007\/978-3-031-70875-6_24"},{"key":"5806_CR49","doi-asserted-by":"crossref","unstructured":"Yisa BM, Aselebe LO, Adeosun AT, Ali MJ, Ibitoye MO (2026) Mathematical modeling of aggregate Fe3O4 nanoparticles in blood with heat generation for cancer therapy application: BM Yisa et al. J Therm Anal Calorim 1\u201314","DOI":"10.1007\/s10973-025-15214-4"},{"key":"5806_CR50","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s13204-021-02312-6","volume":"12","author":"J Yan","year":"2022","unstructured":"Yan J, Xie S, Xia Q, Li X, Chen S, Shen J (2022) Engineering of combination drug delivery of pH\/reduction response potential nanocarrier for the treatment of liver cancer. Appl Nanosci 12:1545\u20131556. https:\/\/doi.org\/10.1007\/s13204-021-02312-6","journal-title":"Appl Nanosci"},{"key":"5806_CR51","doi-asserted-by":"publisher","first-page":"145205","DOI":"10.1016\/j.cej.2023.145205","volume":"473","author":"L Yang","year":"2023","unstructured":"Yang L, Wang X, Zhao Y, Li Y, Wang X, Deng J, Qi Z (2023) Strengthened EPR effect of AIEgen-Poly (I: C) composite nanoparticles to facilitate antigen cross-presentation and improve melanoma prognosis by evoking immunity. Chem Eng J 473:145205","journal-title":"Chem Eng J"},{"key":"5806_CR52","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s11033-025-10838-z","volume":"52","author":"C-Y Yao","year":"2025","unstructured":"Yao C-Y, Chang K-F, Chien J-H, Huang X-F, Chen Y-C, Hsieh M-C, Tsai N-M (2025) Thymus serpyllum extract exerts anticancer activities against colorectal cancer by modulating metastasis, cell cycle arrest, and apoptosis. Mol Biol Rep 52:732","journal-title":"Mol Biol Rep"},{"key":"5806_CR53","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S573349","author":"H Zhang","year":"2026","unstructured":"Zhang H, Zhuang Y, Song J, Shao F, Shi W (2026) Biomimetic nanoplatform based on macrophage membrane-coated Fe3O4 nanoparticles for synergistic ferroptosis and sonodynamic therapy of lung cancer. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S573349","journal-title":"Int J Nanomedicine"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05806-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:04:20Z","timestamp":1786680260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05806-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":53,"alternative-id":["5806"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05806-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}